Témoignages Dirigeants

Testimonials of Members

Marc Karako, VP Finance, Quantum Genomics

Biotech Agora successfully resumed the concept of privileged encounters between individual investors passionate about the health sector and leaders of biotechnology companies. Participants are of high quality and aware of the innovations of the different actors. The formula combines conviviality and personalized relationships in an exclusive setting. In summary, a very good springboard to become better acquainted with individual shareholders particularly active in our field.

Jean-Louis Dasseux, PhD, MBA, founder and Ceo of Cerenis Therapeutics

I very much appreciated the meeting organized by Biotech Agora and the discussions with the people present at the event.

The format, format and quality of the assistance lent itself very well to presentation and discussion.

This type of meeting has a very positive and pedagogical impact: it helps to maintain a link with investors who are very demanding in order to better understand the achievements and prospects of the company. It was also an opportunity to meet new investors who were not familiar with Cerenis and who were passionate about the subject.

Biotech Agora helps to disseminate objective information. This is important in the current context where a lot of misinformation can easily circulate on networks and forums to maintain a direct link with individual investors.

Contact us

Follow us